University of Alberta Transplant Applied Genomics Centre Chooses Scientific Data Management Solution from GenoLogics
News Dec 05, 2007
GenoLogics has announced that the University of Alberta has selected Geneus™ for their informatics infrastructure and scientific data management system. GenoLogics installed Geneus™ at the Alberta Transplant Applied Genomics Centre (ATAGC) at the University of Alberta in September of this year.
ATAGC is conducting diagnostic gene expression and transcriptomics research with the aim to develop new molecular diagnostics for organ transplant recipients.
The research involves using gene expression microarrays to understand transplant rejection events, and has led to the identification of a series of gene expression (transcript) sets that provide new robust quantitative measurements for assessing rejection. These sets form the basis of a potentially new diagnostic system to use in conjunction with the current pathology system.
In the future, they expect to use proteomics and metabolomics research to augment the research they are conducting, and they also plan to partner with pharmaceutical organizations to develop commercial therapeutic drugs to counter organ rejection.
Dr. Philip Halloran, Director of the Alberta Transplant Applied Genomics Centre, stated, “The challenge of applying the new sciences is that they are so rich in data – in information. To be successful in bringing the new genetic sciences to the bedside requires new approaches to managing information. We are doing this in organ transplants now, but every area of medicine will eventually be changed by these new technologies.”
The Geneus solution will be used primarily as a scientific data management system (SDMS) to handle the data management component of the Centre’s gene expression and transcriptomics research. Geneus will provide the research informatics infrastructure to handle the Centre’s massive amount of scientific data.
The ATAGC needed a robust, flexible system, purposed for their science, with an open database schema. They also wanted to work with a collaborative and experienced team that could implement a production solution quickly, and that provided long-term informatics services and support. GenoLogics met these requirements.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.